Tsumura & Co. (TYO:4540)
3,583.00
-105.00 (-2.85%)
May 13, 2025, 3:30 PM JST
Tsumura & Co. Revenue
In the fiscal year ending March 31, 2025, Tsumura & Co. had annual revenue of 181.09B JPY with 20.05% growth. Tsumura & Co. had revenue of 44.32B in the quarter ending March 31, 2025, with 26.56% growth.
Revenue
181.09B
Revenue Growth
+20.05%
P/S Ratio
1.63
Revenue / Employee
41.52M
Employees
4,138
Market Cap
279.32B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 181.09B | 30.25B | 20.05% |
Mar 31, 2024 | 150.85B | 10.80B | 7.71% |
Mar 31, 2023 | 140.04B | 10.50B | 8.10% |
Mar 31, 2022 | 129.55B | -1.34B | -1.02% |
Mar 31, 2021 | 130.88B | 7.64B | 6.19% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,222.12B |
Takeda Pharmaceutical Company | 4,581.55B |
Daiichi Sankyo Company | 1,886.26B |
HOYA Corporation | 869.37B |
Terumo | 1,011.15B |
Otsuka Holdings | 2,393.18B |
Astellas Pharma | 1,912.32B |
Olympus | 993.33B |